Theorem Clinical Research

Global News

Impax completes acquisition of Tower Holdings and Lineage Therapeutics

Wednesday, March 11, 2015 12:43 PM

Impax Laboratories, a pharmaceutical company headquartered in Hayward, Calif., has completed its acquisition of Tower Holdings (including operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics.

More... »

Quest Diagnostics

PharmAthene to cut two-thirds of staff

Wednesday, March 11, 2015 12:32 PM

Annapolis, Md.-based PharmAthene will launch a realignment plan that includes reducing its staffing levels by approximately two-thirds. Eric Richman, president and CEO, will remain a member of the board of directors but will no longer serve as an officer of the company, effective March 11. He will continue to play a key role in managing the ongoing litigation, other legal matters and strategic transactions in his role as director.

More... »


WMIS, National Cancer Institute to collaborate on expansion of co-clinical trials

Wednesday, March 11, 2015 12:29 PM

The World Molecular Imaging Society (WMIS) is collaborating with the National Cancer Institute (NCI), part of the NIH, to promote best practices for co-clinical trials to speed the discovery of more and better treatments for cancer and other diseases.

More... »

Concordia Healthcare to acquire Covis Pharma commercial assets for $1.2B

Wednesday, March 11, 2015 12:28 PM

Concordia Healthcare, a Canada-based diverse healthcare company focused on legacy pharmaceutical products, orphan drugs and medical devices for the diabetic population, will acquire substantially all of the commercial assets of privately held Covis Pharma and Covis Injectables, headquartered in Zug, Switzerland, for $1.2 billion in cash.

More... »

KCR relocates head office to Berlin to bring business closer to clients

Wednesday, March 11, 2015 12:27 PM

KCR, a CRO operating in 19 European countries and the U.S., is relocating its head office from Warsaw, Poland, to Berlin, Germany. The new location will better serve its own customers and support the company’s expanding services and operations.

More... »

AstraZeneca to collaborate with Singapore research organizations on heart failure

Wednesday, March 11, 2015 12:26 PM

AstraZeneca has formed a two-year collaboration with Singapore organizations including the Agency for Science, Technology and Research (A*STAR), National University Heart Center, Singapore (NUHCS) and National University of Singapore to support research into new therapies for heart failure.

More... »

Illumina, Merck Serono collaborate to expand companion diagnostics for oncology

Wednesday, March 11, 2015 12:22 PM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck, based in Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.

More... »

MedImmune, Joslin Diabetes Center collaborate on metabolic disease research

Wednesday, March 11, 2015 12:21 PM

MedImmune, the global biologics R&D arm of AstraZeneca, and Joslin Diabetes Center, a diabetes research and clinical care organization based in Boston, Mass., have inked a three-year research collaboration to develop new medicines for the treatment of diabetes, obesity and related metabolic disorders.

More... »

Biomedical Systems launches next generation eCOA technology

Wednesday, March 11, 2015 12:20 PM

Biomedical Systems, a global provider of centralized diagnostic services headquartered in St. Louis, Mo., launches its second generation clinical outcome assessment software offering three platforms to collect patient data. This new electronic patient recorded outcome (ePRO) technology improves patient and investigator user experience, improves patient compliance and expedites study setup by simplifying site tasks and reducing errors.

More... »

CROS NT extends Datatrak Connect partnership

Monday, March 9, 2015 12:24 PM

CROS NT, an international CRO based in Chapel Hill, N.C., is extending its partnership with Datatrak, a worldwide technology and services company, as part of its life science technology portfolio. The partnership allows CROS NT to provide Datatrak's Unified eClinical platform, which includes Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), randomization and clinical trial supply management (RTSM), as well as a web-based patient diary (ePRO).

More... »

`

CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs